UNH Stock Analysis: Buy, Sell, or Hold?

UNH - UNITEDHEALTH GROUP INCORPORATED (Delaware)

HOSPITAL & MEDICAL SERVICE PLANS
$286.93
-5.36 (-1.83%) β–Ό
WAIT
LOW Confidence
Protect Your UNH Gains
Last Updated: January 30, 2026
Earnings: Apr 16, 2026

Get Alerted When UNH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: UNH is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$573.89
Based on 8.8% avg growth
INTRINSIC VALUE TODAY
$356.34
19.5% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: UNH is currently trading at $286.93, which is considered oversold relative to its 30-day fair value range of $311.68 to $350.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.4) compared to its historical average (18.6). Remarkably, the market is currently pricing in an annual earnings decline of 8.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, UNH is in a downtrend. The price is currently testing key support at $280.40. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $373.60 (+27.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $311.68 - $350.87
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

Protect Your Profits

Holding UNH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 27.8% below Wall St target ($373.60)
  • WARNING: Recommendation downgraded due to -19.5% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $311.68 - $350.87
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $280.40
Resistance Level $357.87
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 14.41
Wall Street Target $373.60 (+27.8%)
Revenue Growth (YoY) 12.3%
Earnings Growth (YoY) -99.8%
Profit Margin 2.7%
Valuation Discount vs History -8.2% cheaper
PE vs Historical 14.4 vs 18.6 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -8.2% (market-implied from PE analysis)
1-Year Target $268.32 (-8%)
2-Year Target $246.32 (-16%)
3-Year Target $226.12 (-23%)
3-Yr Target (if PE normalizes) (PE: 14β†’19) $291.92 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 13.6%) $663.82 (+127%)
Base: (SPY PE: 14.4, Growth: 13.6%) $428.87 (+47%)
Bear: (PE: 12.2, Growth: 13.6%) $364.54 (+25%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 15.31 | Current EPS (TTM): $19.20
Bull Case $341.74 (+19%)
Analyst growth 5.7%, PE expands to 16.8
Base Case $310.67 (+8%)
Market implied 5.7%, PE stable at 15.3
Bear Case $199.93 (-30%)
Severe decline -20.0%, PE contracts to 13.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.4 to 18.6
Stabilization Target: $377.35 (+29.1%)
PE Expansion Potential: +29.1%
Last updated: January 30, 2026 7:41 PM ET
Data refreshes hourly during market hours. Next update: 8:41 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
9
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Markwayne Mullin BUY 2025-09-24
Val T. Hoyle SELL 2025-09-23
Richard McCormick SELL 2025-09-18

Featured in Portfolios

UNH is a key holding in these high-performance investment strategies.

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp
STRONG BUY
28 analysts
$95 61 BUY
CI
Cigna Corp
STRONG BUY
25 analysts
$327 58 HOLD
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$395 53 HOLD
HUM
Humana Inc
HOLD
26 analysts
$288 62 BUY
CNC
Centene Corp
BUY
19 analysts
$44 53 HOLD

Advanced UNH Option Strategies

Professional options setups generated by AI based on today's UNH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for UNH

UNH Technical Chart UNH Price Prediction UNH Earnings Date UNH Investment Advisor UNH Fair Price Analyzer UNH Options Advisor UNH Options Chain UNH Options Analysis UNH Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals